Association Between Cost-Sharing and Buprenorphine Prescription Abandonment.

Kao-Ping ChuaRena M ContiPooja LagisettyAmy S B BohnertUsha NuliyaluThuy D Nguyen

Published in: Journal of general internal medicine (2024)

Among commercially insured and Medicare patients, buprenorphine prescription abandonment is rare and only minimally associated with cost-sharing. Findings suggest elimination of buprenorphine cost-sharing should only be one component of a larger, multi-faceted campaign to increase buprenorphine dispensing.

Keyphrases

end stage renal disease
social media
health information
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
healthcare
patient reported
health insurance